Kohn EC - Search Results

1

Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020.

Das S, Du L, Lee CL, Arhin ND, Chan JA, Kohn EC, Halperin DM, Berlin J, LaFerriere H, Singh S, Kunz PL, Dasari A. Das S, et al. Among authors: kohn ec. JAMA Netw Open. 2021 Oct 1;4(10):e2131744. doi: 10.1001/jamanetworkopen.2021.31744. JAMA Netw Open. 2021. PMID: 34705010 Free PMC article.

2

Proteomics and biomarkers in clinical trials for drug development.

Lee JM, Han JJ, Altwerger G, Kohn EC. Lee JM, et al. Among authors: kohn ec. J Proteomics. 2011 Nov 18;74(12):2632-41. doi: 10.1016/j.jprot.2011.04.023. Epub 2011 May 4. J Proteomics. 2011. PMID: 21570499 Free PMC article. Review.

3

Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence.

Chauhan A, Kohn E, Del Rivero J. Chauhan A, et al. JAMA Oncol. 2020 Jan 1;6(1):21-22. doi: 10.1001/jamaoncol.2019.4568. JAMA Oncol. 2020. PMID: 31697337 Free PMC article. No abstract available.

4

Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.

Lee YC, Wang L, Kohn EC, Rubinstein L, Ivy SP, Harris PJ, Lheureux S. Lee YC, et al. Among authors: kohn ec. Cancer. 2020 May 15;126(10):2139-2145. doi: 10.1002/cncr.32783. Epub 2020 Feb 25. Cancer. 2020. PMID: 32097505 Free PMC article.

5

Proteomics and ovarian cancer: integrating proteomics information into clinical care.

Hays JL, Kim G, Giuroiu I, Kohn EC. Hays JL, et al. Among authors: kohn ec. J Proteomics. 2010 Sep 10;73(10):1864-72. doi: 10.1016/j.jprot.2010.05.013. Epub 2010 Jun 1. J Proteomics. 2010. PMID: 20561909 Free PMC article. Review.

6

Better therapeutic trials in ovarian cancer.

Bookman MA, Gilks CB, Kohn EC, Kaplan KO, Huntsman D, Aghajanian C, Birrer MJ, Ledermann JA, Oza AM, Swenerton KD. Bookman MA, et al. Among authors: kohn ec. J Natl Cancer Inst. 2014 Apr;106(4):dju029. doi: 10.1093/jnci/dju029. Epub 2014 Mar 13. J Natl Cancer Inst. 2014. PMID: 24627272 Free PMC article. Review.

7

Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials.

MacKay HJ, Levine DA, Bae-Jump VL, Bell DW, McAlpine JN, Santin A, Fleming GF, Mutch DG, Nephew KP, Wentzensen N, Goodfellow PJ, Dorigo O, Nijman HW, Broaddus R, Kohn EC. MacKay HJ, et al. Among authors: kohn ec. Oncotarget. 2017 Aug 3;8(48):84579-84594. doi: 10.18632/oncotarget.19961. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137450 Free PMC article. Review.

8

Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting Report.

Harkenrider MM, Markham MJ, Dizon DS, Jhingran A, Salani R, Serour RK, Lynn J, Kohn EC. Harkenrider MM, et al. Among authors: kohn ec. J Natl Cancer Inst. 2020 Nov 1;112(11):1081-1088. doi: 10.1093/jnci/djaa041. J Natl Cancer Inst. 2020. PMID: 32219419 Free PMC article.

9

Cancer invasion and metastases.

Liotta LA, Kohn E. Liotta LA, et al. JAMA. 1990 Feb 23;263(8):1123-6. JAMA. 1990. PMID: 2405205 Review. No abstract available.

10

Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.

Lee JM, Hays JL, Noonan AM, Squires J, Minasian L, Annunziata C, Wood BJ, Yu M, Calvo KR, Houston N, Azad N, Kohn EC. Lee JM, et al. Among authors: kohn ec. Cancer. 2013 Apr 1;119(7):1357-64. doi: 10.1002/cncr.27916. Epub 2012 Dec 20. Cancer. 2013. PMID: 23280317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters